National Cancer Institute; Notice of Closed Meetings, 14571-14572 [E9-7206]

Download as PDF Federal Register / Vol. 74, No. 60 / Tuesday, March 31, 2009 / Notices Dated: March 20, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–6785 Filed 3–30–09; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel Birth Defects Genome-Wide Association Study. Date: April 29, 2009. Time: 2 p.m. to 3:30 p.m. Agenda: To provide concept review of proposed concept review. Place: National Institutes of Health, 6100 Executive Boulevard, Room 5B01, Rockville, MD 20852. (Telephone Conference Call) Contact Person: Sathasiva B. Kandasamy, PhD, Scientific Review Administrator, Division of Scientific Review, National Institute of Child Health, and Human Development, 6100 Executive Boulevard, Room 5B01, Bethesda, MD 20892–9304, (301) 435–6680, skandasa@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) Dated: March 24, 2009 Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–7226 Filed 3–30–09; 8:45 am] tjames on PRODPC61 with NOTICES BILLING CODE 4140–01–P Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel; ‘‘The Screenable Disorders PAR’’. Date: April 30, 2009. Time: 1 p.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6100 Executive Boulevard, Room 5B01, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Norman Chang, PhD, Scientific Review Administrator, Division of Scientific Review, National Institute of Child Health and Human Development, NIH, 6100 Executive Blvd., Room 5B01, Bethesda, MD 20892, (301) 496–1485, changn@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) Dated: March 24, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–7227 Filed 3–30–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Dental & Craniofacial Research; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Advisory Dental and Craniofacial Research VerDate Nov<24>2008 14:35 Mar 30, 2009 Jkt 217001 PO 00000 Frm 00060 Fmt 4703 Sfmt 4703 14571 Council, May 18, 2009, 8:30 a.m. to May 18, 2009, 4:30 p.m., National Institutes of Health, Building 31, 31 Center Drive, Conference Room 10, Bethesda, MD, 20892 which was published in the Federal Register on January 12, 2009, 74 FR 1222. The meeting of the advisory council has been changed from May 18, 2009, to May 22, 2009. The meeting is partially closed to the public. Dated: March 20, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–6783 Filed 3–30–09; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel, ‘‘Develop Automated Methods to Identify Environmental Exposure Patterns in Satellite Imagery Data.’’ Date: April 15, 2009. Time: 12:45 p.m. to 1:45 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 6116 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Kirt Vener, PhD, Branch Chief, Special Review And Logistics Branch, Division Of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Room 8061, Bethesda, MD 20892–8329. 301– 496–7174, venerk@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Molecular Oncology. Date: June 3–5, 2009. Time: 8 a.m. to 5 p.m. E:\FR\FM\31MRN1.SGM 31MRN1 tjames on PRODPC61 with NOTICES 14572 Federal Register / Vol. 74, No. 60 / Tuesday, March 31, 2009 / Notices Agenda: To review and evaluate grant applications. Place: Hilton—DC/Rockville, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Michael B. Small, PhD, Scientific Review Officer, Division of Extramural Activities, National Cancer Institute, National Institutes of Health, 6116 Executive Blvd., Room 8127, Bethesda, MD 20892–8328. 301–402–0996. smallm@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, NCI Clinical Studies. Date: June 15–17, 2009. Time: 3 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Washington/Rockville, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Majed M. Hamawy, PhD, MBA, Scientific Review Officer, Research Programs Review Branch, Division of Extramual Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 8135, Bethesda, MD 20852. 301–594– 5659. mh101v@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Cancer Prevention, Control and Population Sciences. Date: June 16–17, 2009. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Hilton—Rockville, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Wlodek Lopaczynski, MD, PhD, Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd., Room 8131, Bethesda, MD 20892. 301–594–1402. lopacw@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, SPORE Review. Date: June 16–18, 2009. Time: 4 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, Bethesda, MD 20852. Contact Person: Shamala K. Srinivas, PhD, Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 8123, Bethesda, MD 20892, 301–594–1224, ss537t@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Application Use of Transformative Emerging Technologies in Cancer Research. Date: June 22–23, 2009. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814. Contact Person: Viatcheslav A. Soldatenkov, MD, PhD, Scientific Review Officer, Special Review And Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd., Room 8050a, Bethesda, MD 20892– VerDate Nov<24>2008 14:35 Mar 30, 2009 Jkt 217001 8329, 301–451–4758, soldatenkovv@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: March 24, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–7206 Filed 3–30–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Drug Abuse; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meeting will he closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; Loan Repayment. Date: March 30, 2009. Time: 9 a.m. to 5p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6101 Executive Boulevard, Rockville, MD 20852 (Virtual Meeting). Contact Person: Lyle Furr, Contract Review Specialist, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892–8401, (301) 435–1439, lf33c.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; Mouse Gene Development Initiative. Date: May 6, 2009. Time: 8 a.m. to 5 p.m. PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 Agenda: To review and evaluate grant applications. Place: Doubletree Hotel, 8120 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Minna Liang, PhD, Scientific Review Officer, Training and Special Projects Review Branch, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, 6101 Executive Blvd., Room 220, MSC 8401, Bethesda, MD 20852, 301–435–1432, liangm@nida.nih.gov. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; Brain Imaging Studies of Negative Reinforcement in Humans. Date: May 29, 2009. Time: 8:30 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road, NW., Washington, DC 20015. Contact Person: Kristen V Huntley, PhD, Scientific Review Administrator, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892–8401, 301–435–1433, huntleyk@mail.nih.gov. Name of Committee: National Institute on Drug Abuse Initial Review Group; Health Services Research Subcommittee. Date: June 9–10, 2009, Time: 8:30 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Madison Lowes Hotel, 1177 Fifteenth Street, NW., Washington, DC 20005. Contact Person: Meenaxi Hiremath, PhD, Health Scientist Administrator, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6101 Executive Blvd., Suite 220, MSC 8401, Bethesda, MD 20892, 301–402–7964, mh392g@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS) Dated: March 20, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–6781 Filed 3–30–09; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Drug Abuse; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meeting will be closed to the public in accordance with the E:\FR\FM\31MRN1.SGM 31MRN1

Agencies

[Federal Register Volume 74, Number 60 (Tuesday, March 31, 2009)]
[Notices]
[Pages 14571-14572]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-7206]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, ``Develop Automated Methods to Identify Environmental 
Exposure Patterns in Satellite Imagery Data.''
    Date: April 15, 2009.
    Time: 12:45 p.m. to 1:45 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Rockville, MD 20852 (Telephone Conference Call).
    Contact Person: Kirt Vener, PhD, Branch Chief, Special Review 
And Logistics Branch, Division Of Extramural Activities, National 
Cancer Institute, NIH, 6116 Executive Blvd., Room 8061, Bethesda, MD 
20892-8329. 301-496-7174, venerk@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Molecular Oncology.
    Date: June 3-5, 2009.
    Time: 8 a.m. to 5 p.m.

[[Page 14572]]

    Agenda: To review and evaluate grant applications.
    Place: Hilton--DC/Rockville, 1750 Rockville Pike, Rockville, MD 
20852.
    Contact Person: Michael B. Small, PhD, Scientific Review 
Officer, Division of Extramural Activities, National Cancer 
Institute, National Institutes of Health, 6116 Executive Blvd., Room 
8127, Bethesda, MD 20892-8328. 301-402-0996. smallm@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, NCI Clinical Studies.
    Date: June 15-17, 2009.
    Time: 3 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington/Rockville, 1750 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Majed M. Hamawy, PhD, MBA, Scientific Review 
Officer, Research Programs Review Branch, Division of Extramual 
Activities, National Cancer Institute, NIH, 6116 Executive 
Boulevard, Room 8135, Bethesda, MD 20852. 301-594-5659. 
mh101v@nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Cancer Prevention, Control and Population Sciences.
    Date: June 16-17, 2009.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton--Rockville, 1750 Rockville Pike, Rockville, MD 
20852.
    Contact Person: Wlodek Lopaczynski, MD, PhD, Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, 6116 Executive Blvd., Room 
8131, Bethesda, MD 20892. 301-594-1402. lopacw@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, SPORE Review.
    Date: June 16-18, 2009.
    Time: 4 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Shamala K. Srinivas, PhD, Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, 6116 Executive Boulevard, 
Room 8123, Bethesda, MD 20892, 301-594-1224, ss537t@nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Application Use of Transformative Emerging Technologies in 
Cancer Research.
    Date: June 22-23, 2009.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 
20814.
    Contact Person: Viatcheslav A. Soldatenkov, MD, PhD, Scientific 
Review Officer, Special Review And Logistics Branch, Division of 
Extramural Activities, National Cancer Institute, 6116 Executive 
Blvd., Room 8050a, Bethesda, MD 20892-8329, 301-451-4758, 
soldatenkovv@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: March 24, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-7206 Filed 3-30-09; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.